Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kumara V. Subramanian"'
Autor:
Brian D. Kangas, Marcus S. Delatte, Ganesh A. Thakur, Kumara V. Subramanian, V. Kiran Vemuri, Alexandros Makriyannis, Jack Bergman, Spyridon P. Nikas, Vidyanand G. Shukla
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 344:561-567
Cannabinoid receptor 1 (CB(1)) inverse agonists (e.g., rimonabant) have been reported to produce adverse effects including nausea, emesis, and anhedonia that limit their clinical applications. Recent laboratory studies suggest that the effects of CB(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82d50dfb53917abdc0c5aa13bf37945
https://doi.org/10.1124/jpet.112.201962
https://doi.org/10.1124/jpet.112.201962
Autor:
Alexandros Makriyannis, Spyros P. Nikas, Jack Bergman, Kumara V. Subramanian, Michael Z. Leonard, Vidyanand G. Shukla, Brian D. Kangas, Ganesh A. Thakur
Publikováno v:
The FASEB Journal. 27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a4756f5b18dd5f07bd5e0fcb6a9099c
https://doi.org/10.1096/fasebj.27.1_supplement.lb532
https://doi.org/10.1096/fasebj.27.1_supplement.lb532
Autor:
Jack Bergman, Kumara V. Subramanian, Brian D. Kangas, Spyros P. Nikas, Vidyanand G. Shukla, Alexandros Makriyannis
Publikováno v:
Behavioural Pharmacology. 24:e62
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d03dcb85e1476a6e4163215ef745e22b
https://doi.org/10.1097/01.fbp.0000434885.08189.06
https://doi.org/10.1097/01.fbp.0000434885.08189.06